Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Gene expression in thyroid autonomous adenomas provides insight into their physiopathology

Oncogene volume 24, pages 6902–6916 (2005)Cite this article

Abstract

The purpose of this study was to use the microarray technology to define expression profiles characteristic of thyroid autonomous adenomas and relate these findings to physiological mechanisms. Experiments were performed on a series of separated adenomas and their normal counterparts on Micromax cDNA microarrays covering 2400 genes (analysis I), and on a pool of adenomatous tissues and their corresponding normal counterparts using microarrays of 18 000 spots (analysis II). Results for genes present on the two arrays corroborated and several gene regulations previously determined by Northern blotting or microarrays in similar lesions were confirmed. Five overexpressed and 24 underexpressed genes were also confirmed by real-time RT–PCR in some of the samples used for microarray analysis, and in additional tumor specimens. Our results show: (1) a change in the cell populations of the tumor, with a marked decrease in lymphocytes and blood cells and an increase in endothelial cells. The latter increase would correspond to the establishment of a close relation between thyrocytes and endothelial cells and is related to increased N-cadherin expression. It explains the increased blood flow in the tumor; (2) a homogeneity of tumor samples correlating with their common physiopathological mechanism: the constitutive activation of the thyrotropin (TSH)/cAMP cascade; (3) a low proportion of regulated genes consistent with the concept of a minimal deviation tumor; (4) a higher expression of genes coding for specific functional proteins, consistent with the functional hyperactivity of the tumors; (5) an increase of phosphodiesterase gene expression which explains the relatively low cyclic AMP levels measured in these tumors; (6) an overexpression of antiapoptotic genes and underexpression of proapoptotic genes compatible with their low apoptosis rate; (7) an overexpression of N-cadherin and downregulation of caveolins, which casts doubt about the use of these expressions as markers for malignancy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Aldred MA, Ginn-Pease ME, Morrison CD, Popkie AP, Gimm O, Hoang-Vu C, Krause U, Dralle H, Jhiang SM, Plass C and Eng C . (2003). Cancer Res., 63, 2864–2871.

  • Aldred MA, Huang Y, Liyanarachchi S, Pellegata NS, Gimm O, Jhiang S, Davuluri RV, de la CA and Eng C . (2004). J. Clin. Oncol., 22, 3531–3539.

  • Aust G, Steinert M, Kiessling S, Kamprad M and Simchen C . (2001). J. Clin. Endocrinol. Metab., 86, 3368–3376.

  • Baptist M, Dumont JE and Roger PP . (1995). Exp. Cell Res., 221, 160–171.

  • Barden CB, Shister KW, Zhu B, Guiter G, Greenblatt DY, Zeiger MA and Fahey III TJ . (2003). Clin. Cancer Res., 9, 1792–1800.

  • Baris O, Savagner F, Nasser V, Loriod B, Granjeaud S, Guyetant S, Franc B, Rodien P, Rohmer V, Bertucci F, Birnbaum D, Malthiery Y, Reynier P and Houlgatte R . (2004). J. Clin. Endocrinol. Metab., 89, 994–1005.

  • Bauch K . (1998). Exp. Clin. Endocrinol. Diabetes, 106 (Suppl 4), S16–S22.

  • Becker D, Bair HJ, Becker W, Gunter E, Lohner W, Lerch S and Hahn EG . (1997). J. Clin. Ultrasound, 25, 63–69.

  • Bourdeau I, Antonini SR, Lacroix A, Kirschner LS, Matyakhina L, Lorang D, Libutti SK and Stratakis CA . (2004). Oncogene, 23, 1575–1585.

  • Carver LA and Schnitzer JE . (2003). Nat. Rev. Cancer, 3, 571–581.

  • Cho-Chung YS . (2004). Biochim. Biophys. Acta, 1697, 71–79.

  • Corvilain B, Van Sande J, Dumont JE and Vassart G . (2001). Clin. Endocrinol. (Oxford), 55, 143–158.

  • Deleu S, Allory Y, Radulescu A, Pirson I, Carrasco N, Corvilain B, Salmon I, Franc B, Dumont JE, Van Sande J and Maenhaut C . (2000). Thyroid, 10, 131–140.

  • Detours V, Wattel S, Venet D, Hutsebaut N, Bogdanova T, Tronko MD, Dumont JE, Franc B, Thomas G and Maenhaut C . (2005). Br. J. Cancer, 92, 1545–1552.

  • Dralle H and Bocker W . (1977). Virchows Arch. A Pathol. Anat. Histol., 374, 285–301.

  • Dremier S, Coulonval K, Perpete S, Vandeput F, Fortemaison N, Van Keymeulen A, Deleu S, Ledent C, Clement S, Schurmans S, Dumont JE, Lamy F, Roger PP and Maenhaut C . (2002). Ann. NY. Acad. Sci., 968, 106–121.

  • Dumont JE, Jauniaux JC and Roger PP . (1989). Trends Biochem. Sci., 14, 67–71.

  • Eggo MC, King WJ, Black EG and Sheppard MC . (1996). J. Clin. Endocrinol. Metab., 81, 3056–3062.

  • Ermans AM and Camus M . (1972). Acta Endocrinol. (Copenhagen), 70, 463–475.

  • Eszlinger M, Krohn K, Frenzel R, Kropf S, Tonjes A and Paschke R . (2004). Oncogene, 23, 795–804.

  • Eszlinger M, Krohn K and Paschke R . (2001). J. Clin. Endocrinol. Metab., 86, 4834–4842.

  • Finley DJ, Arora N, Zhu B, Gallagher L and Fahey III TJ . (2004). J. Clin. Endocrinol. Metab., 89, 3214–3223.

  • Fuhrer D, Holzapfel HP, Wonerow P, Scherbaum WA and Paschke R . (1997). J. Clin. Endocrinol. Metab., 82, 3885–3891.

  • Gerard AC, Many MC, Daumerie C, Costagliola S, Miot F, DeVijlder JJ, Colin IM and Denef JF . (2002). J. Clin. Endocrinol. Metab., 87, 1291–1299.

  • Goffard JC, Jin L, Mircescu H, Van Hummelen P, Ledent C, Dumont JE and Corvilain B . (2004). Mol. Endocrinol., 18, 194–213.

  • Hamburger JI . (1987). Endocr. Rev., 8, 439–447.

  • Hanasaki K, Varki A and Powell LD . (1995). J. Biol. Chem., 270, 7533–7542.

  • Haugen DR, Fluge O, Reigstad LJ, Varhaug JE and Lillehaug JR . (2003). Thyroid, 13, 613–620.

  • Huang Y, Prasad M, Lemon WJ, Hampel H, Wright FA, Kornacker K, LiVolsi V, Frankel W, Kloos RT, Eng C, Pellegata NS and de la CA . (2001). Proc. Natl. Acad. Sci. USA, 98, 15044–15049.

  • Husmark J, Heldin NE and Nilsson M . (1999). Int. J. Cancer, 83, 692–699.

  • Karsten SL, Van Deerlin VM, Sabatti C, Gill LH and Geschwind DH . (2002). Nucleic Acids Res., 30, E4.

  • Ketelbant-Balasse P, Van Sande J, Neve P and Dumont JE . (1976). Horm. Metab. Res., 8, 212–215.

  • Knudsen N, Bulow I, Jorgensen T, Laurberg P, Ovesen L and Perrild H . (2000). Eur. J. Endocrinol., 143, 485–491.

  • Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G and Kallioniemi OP . (1998). Nat. Med., 4, 844–847.

  • Krohn K, Fuhrer D, Holzapfel HP and Paschke R . (1998). J. Clin. Endocrinol. Metab., 83, 130–134.

  • Krohn K, Wohlgemuth S, Gerber H and Paschke R . (2000). J. Pathol., 192, 37–42.

  • Lania A, Persani L, Ballare E, Mantovani S, Losa M and Spada A . (1998). J. Clin. Endocrinol. Metab., 83, 1624–1628.

  • Ledent C, Dumont JE, Vassart G and Parmentier M . (1992). EMBO J., 11, 537–542.

  • Mazzanti C, Zeiger MA, Costouros NG, Umbricht C, Westra WH, Smith D, Somervell H, Bevilacqua G, Alexander HR and Libutti SK . (2004). Cancer Res., 64, 2898–2903.

  • Michiels FM, Caillou B, Talbot M, Dessarps-Freichey F, Maunoury MT, Schlumberger M, Mercken L, Monier R and Feunteun J . (1994). Proc. Natl. Acad. Sci. USA, 91, 10488–10492.

  • Namba H, Matsuo K and Fagin JA . (1990). J. Clin. Invest., 86, 120–125.

  • Neve P and Dumont JE . (1970). Exp. Cell Res., 63, 285–292.

  • Nilson JH, Orlicky DJ and Kerkof PR . (1980). Endocrinology, 107, 262–269.

  • O'Donovan N, Fischer A, Abdo EM, Simon F, Peter HJ, Gerber H, Buergi U and Marti U . (2002). J. Endocrinol., 174, 517–524.

  • Persani L, Lania A, Alberti L, Romoli R, Mantovani G, Filetti S, Spada A and Conti M . (2000). J. Clin. Endocrinol. Metab., 85, 2872–2878.

  • Pfaffl MW . (2001). Nucleic Acids Res., 29, e45.

  • Pirson I, Coulonval K, Lamy F and Dumont JE . (1996). J. Cell. Physiol., 168, 59–70.

  • Pirson I, Reuse S and Dumont JE . (1994). Exp. Cell Res., 210, 33–38.

  • Puskas LG, Zvara A, Hackler Jr L and Van Hummelen P . (2002). Biotechniques, 32, 1330–1334, 1336, 1338, 1340.

  • Reuse S, Maenhaut C and Dumont JE . (1990). Exp. Cell Res., 189, 33–40.

  • Rieger-Christ KM, Lee P, Zagha R, Kosakowski M, Moinzadeh A, Stoffel J, Ben Ze'ev A, Libertino JA and Summerhayes IC . (2004). Oncogene, 23, 4745–4753.

  • Roger PP and Dumont JE . (1984). Mol. Cell. Endocrinol., 36, 79–93.

  • Russo D, Arturi F, Wicker R, Chazenbalk GD, Schlumberger M, DuVillard JA, Caillou B, Monier R, Rapoport B and Filetti S . (1995). J. Clin. Endocrinol. Metab., 80, 1347–1351.

  • Savonet V, Maenhaut C, Miot F and Pirson I . (1997). Anal. Biochem., 247, 165–167.

  • Taniguchi M, Miura K, Iwao H and Yamanaka S . (2001). Genomics, 71, 34–39.

  • Tonacchera M, Agretti P, Chiovato L, Rosellini V, Ceccarini G, Perri A, Viacava P, Naccarato AG, Miccoli P, Pinchera A and Vitti P . (2000). J. Clin. Endocrinol. Metab., 85, 2270–2274.

  • Tonacchera M, Vitti P, Agretti P, Ceccarini G, Perri A, Cavaliere R, Mazzi B, Naccarato AG, Viacava P, Miccoli P, Pinchera A and Chiovato L . (1999). J. Clin. Endocrinol. Metab., 84, 4155–4158.

  • van den Hove-Vandenbroucke MF, De Visscher M and Couvreur-Eppe M . (1976). J. Clin. Endocrinol. Metab., 43, 178–181.

  • Van Sande J, Lamy F, Lecocq R, Mirkine N, Rocmans P, Cochaux P, Mockel J and Dumont JE . (1988). J. Clin. Endocrinol. Metab., 66, 570–579.

  • Van Sande J, Mockel J, Boeynaems JM, Dor P, Andry G and Dumont JE . (1980). J. Clin. Endocrinol. Metab., 50, 776–785.

  • Van Sande J, Parma J, Tonacchera M, Swillens S, Dumont J and Vassart G . (1995). J. Clin. Endocrinol. Metab., 80, 2577–2585.

  • Vandeput F, Perpete S, Coulonval K, Lamy F and Dumont JE . (2003). Endocrinology, 144, 1341–1349.

  • Vanvooren V, Uchino S, Duprez L, Costa MJ, Vandekerckhove J, Parma J, Vassart G, Dumont JE, Van Sande J and Noguchi S . (2002). Eur. J. Endocrinol., 147, 287–291.

  • Venet D . (2003). Bioinformatics, 19, 659–660.

  • Venet D, Pecasse F, Maenhaut C and Bersini H . (2001). Bioinformatics, 17 (Suppl 1), S279–S287.

  • Voigt C, Holzapfel HP, Meyer S and Paschke R . (2004). J. Endocrinol., 182, 173–182.

  • Wang H, Frelin L and Pevsner J . (1997). Gene, 199, 39–48.

  • Weber G . (2002). Adv. Enzyme Regul., 42, 83–100.

  • Wollman SH, Herveg JP and Smeds S . (1982). Endocrinology, 111, 1867–1873.

  • Wollman SH, Herveg JP, Zeligs JD and Ericson LE . (1978). Endocrinology, 103, 2306–2314.

  • Yamazaki K, Yamada E, Kanaji Y, Yanagisawa T, Kato Y, Takano K, Obara T and Sato K . (2003). Thyroid, 13, 149–158.

  • Yang YH, Dudoit S, Luu P, Lin DM, Peng V, Ngai J and Speed TP . (2002). Nucleic Acids Res., 30, e15.

  • Yano Y, Uematsu N, Yashiro T, Hara H, Ueno E, Miwa M, Tsujimoto G, Aiyoshi Y and Uchida K . (2004). Clin. Cancer Res., 10, 2035–2043.

  • Zeiger MA, Saji M, Gusev Y, Westra WH, Takiyama Y, Dooley WC, Kohn LD and Levine MA . (1997). Endocrinology, 138, 3133–3140.

Download references

Acknowledgements

We thank Chantal Degraef for excellent technical assistance. This work was supported by the Ministère de la Politique Scientifique (PAI), the Fonds de la Recherche Scientifique Médicale, Télévie, Fédération Belge contre le Cancer, Fondation Wiener-Anspach, Fondation Van Buuren, Fortis Banque Assurances and UCB-Région Wallonne. Hortensia Mircescu was supported by a fellowship grant from the Fonds de la recherche en santé du Québec and by a grant from the Philippe Wiener-Maurice Anspach Foundation.

Author information

Authors and Affiliations

  1. Institute of Interdisciplinary Research, School of Medicine, Free University of Brussels, Brussels, Belgium

    Sandrine Wattel, Hortensia Mircescu, David Venet, Agnes Burniat, Sandra Frank, Jacqueline Van Sande, Pierre Rocmans, Jacques E Dumont, Vincent Detours & Carine Maenhaut

  2. Service d'Anatomie et de Cytologie Pathologiques, Hôpital A Paré (AP-HP), Université de Versailles, St-Quentin-en-Yvelines, France

    Brigitte Franc

  3. Department of Surgery, Institut Bordet, Brussels, 1000, Belgium

    Guy Andry

Authors
  1. Sandrine Wattel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hortensia Mircescu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David Venet
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Agnes Burniat
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Brigitte Franc
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sandra Frank
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Guy Andry
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jacqueline Van Sande
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Pierre Rocmans
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Jacques E Dumont
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Vincent Detours
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Carine Maenhaut
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Carine Maenhaut.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wattel, S., Mircescu, H., Venet, D. et al. Gene expression in thyroid autonomous adenomas provides insight into their physiopathology. Oncogene 24, 6902–6916 (2005). https://doi.org/10.1038/sj.onc.1208849

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1208849

Keywords

This article is cited by

Search

Advanced search

Quick links